Royalty Pharma
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Royalty Pharma
Royalty Pharma plc 作為生物製藥特許權使用費的購買者和美國生物製藥行業創新的資助者運營。它還參與各種生物製藥療法的特許權使用費的鑑定、評估和收購。此外，該公司還與來自學術機構、研究醫院和非營利組織、中小型生物技術公司和製藥公司的創新者合作。其產品組合包括約 35 種已上市療法的特許權使用費和 10 種處於開發階段的候選產品，涉及罕見疾病、癌症、神經病學、傳染病、血液學和糖尿病等不同治療領域。該公司成立於 1996 年，總部位於紐約州紐約市。
如何購買 Royalty Pharma (RPRX)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 RPRX
透過 RockFlow App 或網頁端搜尋 RPRX，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.